Spok Holdings, Inc. (NASDAQ: SPOK) Stock Competitors & Peer Comparison
See SPOK's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SPOK and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SPOK | $11.76 | +0.09% | 245.2M | 13.19 | $0.89 | +10.63% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| TEM | $76.05 | +7.98% | 13.5B | -152.08 | -$0.50 | N/A |
| BTSGU | $212.10 | -1.95% | 13.4B | 129.05 | $1.71 | N/A |
| BTSG | $67.15 | +1.96% | 13.4B | 39.26 | $1.71 | N/A |
| HNGE | $115.76 | -0.19% | 9.3B | 61.90 | $1.87 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $103.63 | +0.16% | 8.6B | 24.20 | $4.28 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| DOCS | $32.51 | -2.02% | 5.8B | 21.25 | $1.53 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
SPOK vs GEHCV Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to GEHCV's ROE of +0.20%. Regarding short-term risk, SPOK is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check GEHCV's competition here
Tempus AI, Inc. (NASDAQ: TEM)
SPOK vs TEM Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, TEM has a market cap of 13.5B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while TEM trades at $76.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas TEM's P/E ratio is -152.08. In terms of profitability, SPOK's ROE is +0.13%, compared to TEM's ROE of -0.41%. Regarding short-term risk, SPOK is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check TEM's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
SPOK vs BTSGU Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, BTSGU has a market cap of 13.4B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while BTSGU trades at $212.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas BTSGU's P/E ratio is 129.05. In terms of profitability, SPOK's ROE is +0.13%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, SPOK is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
SPOK vs BTSG Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, BTSG has a market cap of 13.4B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while BTSG trades at $67.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas BTSG's P/E ratio is 39.26. In terms of profitability, SPOK's ROE is +0.13%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, SPOK is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check BTSG's competition here
Hinge Health, Inc. (NYSE: HNGE)
SPOK vs HNGE Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, HNGE has a market cap of 9.3B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while HNGE trades at $115.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas HNGE's P/E ratio is 61.90. In terms of profitability, SPOK's ROE is +0.13%, compared to HNGE's ROE of +0.50%. Regarding short-term risk, SPOK is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HNGE's competition here
Signify Health, Inc. (NYSE: SGFY)
SPOK vs SGFY Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SGFY's P/E ratio is 70.91. In terms of profitability, SPOK's ROE is +0.13%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, SPOK is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
SPOK vs HQY Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, HQY has a market cap of 8.6B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while HQY trades at $103.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas HQY's P/E ratio is 24.20. In terms of profitability, SPOK's ROE is +0.13%, compared to HQY's ROE of +0.11%. Regarding short-term risk, SPOK is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HQY's competition here
R1 RCM Inc. (NASDAQ: RCM)
SPOK vs RCM Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas RCM's P/E ratio is -102.21. In terms of profitability, SPOK's ROE is +0.13%, compared to RCM's ROE of +0.00%. Regarding short-term risk, SPOK is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
SPOK vs DOCS Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, DOCS has a market cap of 5.8B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while DOCS trades at $32.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas DOCS's P/E ratio is 21.25. In terms of profitability, SPOK's ROE is +0.13%, compared to DOCS's ROE of +0.15%. Regarding short-term risk, SPOK is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
SPOK vs WAY Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, WAY has a market cap of 5.5B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while WAY trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas WAY's P/E ratio is 18.77. In terms of profitability, SPOK's ROE is +0.13%, compared to WAY's ROE of +0.03%. Regarding short-term risk, SPOK is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check WAY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
SPOK vs HTFL Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, HTFL has a market cap of 4.6B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while HTFL trades at $52.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas HTFL's P/E ratio is -26.07. In terms of profitability, SPOK's ROE is +0.13%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, SPOK is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
SPOK vs ONEM Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SPOK's ROE is +0.13%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SPOK is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
SPOK vs PRVA Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, PRVA has a market cap of 3.1B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while PRVA trades at $24.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas PRVA's P/E ratio is 116.33. In terms of profitability, SPOK's ROE is +0.13%, compared to PRVA's ROE of +0.05%. Regarding short-term risk, SPOK is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check PRVA's competition here
Certara, Inc. (NASDAQ: CERT)
SPOK vs CERT Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CERT has a market cap of 1.8B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CERT trades at $12.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CERT's P/E ratio is 30.07. In terms of profitability, SPOK's ROE is +0.13%, compared to CERT's ROE of -0.06%. Regarding short-term risk, SPOK is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check CERT's competition here
Omnicell, Inc. (NASDAQ: OMCL)
SPOK vs OMCL Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, OMCL has a market cap of 1.7B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while OMCL trades at $37.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas OMCL's P/E ratio is 19.57. In terms of profitability, SPOK's ROE is +0.13%, compared to OMCL's ROE of +0.04%. Regarding short-term risk, SPOK is less volatile compared to OMCL. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check OMCL's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
SPOK vs NXGN Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SPOK's ROE is +0.13%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SPOK is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
SPOK vs TDOC Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while TDOC trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas TDOC's P/E ratio is -10.17. In terms of profitability, SPOK's ROE is +0.13%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, SPOK is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
SPOK vs AGTI Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SPOK's ROE is +0.13%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, SPOK is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
SPOK vs GDRX Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while GDRX trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas GDRX's P/E ratio is 11.00. In terms of profitability, SPOK's ROE is +0.13%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, SPOK is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check GDRX's competition here
Omada Health (NASDAQ: OMDA)
SPOK vs OMDA Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, OMDA has a market cap of 922.8M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while OMDA trades at $15.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas OMDA's P/E ratio is 65.54. In terms of profitability, SPOK's ROE is +0.13%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, SPOK is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check OMDA's competition here
HealthStream, Inc. (NASDAQ: HSTM)
SPOK vs HSTM Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, HSTM has a market cap of 883M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while HSTM trades at $28.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas HSTM's P/E ratio is 40.08. In terms of profitability, SPOK's ROE is +0.13%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, SPOK is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
SPOK vs CCLDO Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to CCLDO's ROE of +0.24%. Regarding short-term risk, SPOK is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
SPOK vs PHR Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, PHR has a market cap of 783.6M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while PHR trades at $12.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas PHR's P/E ratio is 45.09. In terms of profitability, SPOK's ROE is +0.13%, compared to PHR's ROE of +0.03%. Regarding short-term risk, SPOK is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
SPOK vs MPLN-WT Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, SPOK is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MPLN-WT's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
SPOK vs SOPH Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SOPH has a market cap of 607.8M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SOPH trades at $7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SOPH's P/E ratio is -6.43. In terms of profitability, SPOK's ROE is +0.13%, compared to SOPH's ROE of -1.33%. Regarding short-term risk, SPOK is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SOPH's competition here
Accolade, Inc. (NASDAQ: ACCD)
SPOK vs ACCD Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SPOK's ROE is +0.13%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, SPOK is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check ACCD's competition here
NRC Health (NASDAQ: NRC)
SPOK vs NRC Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, NRC has a market cap of 572M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while NRC trades at $25.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas NRC's P/E ratio is 31.54. In terms of profitability, SPOK's ROE is +0.13%, compared to NRC's ROE of +1.03%. Regarding short-term risk, SPOK is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check NRC's competition here
Sharecare, Inc. (NASDAQ: SHCR)
SPOK vs SHCR Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SPOK's ROE is +0.13%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, SPOK is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
SPOK vs EVH Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, EVH has a market cap of 514M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while EVH trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas EVH's P/E ratio is 35.15. In terms of profitability, SPOK's ROE is +0.13%, compared to EVH's ROE of -1.30%. Regarding short-term risk, SPOK is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check EVH's competition here
Carlsmed, Inc. (NASDAQ: CARL)
SPOK vs CARL Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CARL has a market cap of 396.4M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CARL trades at $14.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CARL's P/E ratio is -10.15. In terms of profitability, SPOK's ROE is +0.13%, compared to CARL's ROE of -0.38%. Regarding short-term risk, SPOK is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check CARL's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
SPOK vs SLGC Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SLGC's P/E ratio is -3.04. In terms of profitability, SPOK's ROE is +0.13%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, SPOK is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
SPOK vs SLGCW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, SPOK's ROE is +0.13%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, SPOK is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
SPOK vs TBRG Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas TBRG's P/E ratio is 9.37. In terms of profitability, SPOK's ROE is +0.13%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, SPOK is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check TBRG's competition here
Claritev Corporation (NYSE: CTEV)
SPOK vs CTEV Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CTEV has a market cap of 386.7M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CTEV trades at $22.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CTEV's P/E ratio is -1.34. In terms of profitability, SPOK's ROE is +0.13%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, SPOK is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN)
SPOK vs MPLN Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SPOK's ROE is +0.13%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, SPOK is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MPLN's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
SPOK vs TRHC Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SPOK's ROE is +0.13%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SPOK is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
SPOK vs SY Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SY has a market cap of 268.1M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SY trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SY's P/E ratio is -6.21. In terms of profitability, SPOK's ROE is +0.13%, compared to SY's ROE of -0.16%. Regarding short-term risk, SPOK is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
SPOK vs SMFR Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SMFR's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, SPOK is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SMFR's competition here
American Well Corporation (NYSE: AMWL)
SPOK vs AMWL Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, AMWL has a market cap of 183.9M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while AMWL trades at $11.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas AMWL's P/E ratio is -2.71. In terms of profitability, SPOK's ROE is +0.13%, compared to AMWL's ROE of -0.25%. Regarding short-term risk, SPOK is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check AMWL's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
SPOK vs OPRX Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, OPRX has a market cap of 164.8M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while OPRX trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas OPRX's P/E ratio is 8.03. In terms of profitability, SPOK's ROE is +0.13%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, SPOK is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
SPOK vs LFMDP Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, LFMDP has a market cap of 145.1M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while LFMDP trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas LFMDP's P/E ratio is -655.78. In terms of profitability, SPOK's ROE is +0.13%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, SPOK is less volatile compared to LFMDP. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check LFMDP's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
SPOK vs CPSI Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SPOK's ROE is +0.13%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, SPOK is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check CPSI's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
SPOK vs DH Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, DH has a market cap of 121.7M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while DH trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas DH's P/E ratio is 4.38. In terms of profitability, SPOK's ROE is +0.13%, compared to DH's ROE of -0.83%. Regarding short-term risk, SPOK is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check DH's competition here
Augmedix, Inc. (NASDAQ: AUGX)
SPOK vs AUGX Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SPOK's ROE is +0.13%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, SPOK is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check AUGX's competition here
LifeMD, Inc. (NASDAQ: LFMD)
SPOK vs LFMD Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, LFMD has a market cap of 114.1M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while LFMD trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas LFMD's P/E ratio is -4.73. In terms of profitability, SPOK's ROE is +0.13%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, SPOK is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check LFMD's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
SPOK vs HCAT Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, HCAT has a market cap of 110.6M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while HCAT trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas HCAT's P/E ratio is 7.35. In terms of profitability, SPOK's ROE is +0.13%, compared to HCAT's ROE of -1.28%. Regarding short-term risk, SPOK is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HCAT's competition here
CareCloud, Inc. (NASDAQ: CCLD)
SPOK vs CCLD Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CCLD has a market cap of 96.9M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CCLD trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CCLD's P/E ratio is 8.77. In terms of profitability, SPOK's ROE is +0.13%, compared to CCLD's ROE of +0.24%. Regarding short-term risk, SPOK is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check CCLD's competition here
Forian Inc. (NASDAQ: FORA)
SPOK vs FORA Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas FORA's P/E ratio is -24.11. In terms of profitability, SPOK's ROE is +0.13%, compared to FORA's ROE of -0.17%. Regarding short-term risk, SPOK is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
SPOK vs CCLDP Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to CCLDP's ROE of +0.24%. Regarding short-term risk, SPOK is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
SPOK vs SNCE Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SPOK's ROE is +0.13%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SPOK is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
SPOK vs AKLI Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SPOK's ROE is +0.13%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, SPOK is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
SPOK vs SHLT Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SHLT's P/E ratio is -3.87. In terms of profitability, SPOK's ROE is +0.13%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, SPOK is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
SPOK vs SHCRW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, SPOK's ROE is +0.13%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, SPOK is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMD)
SPOK vs ONMD Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, ONMD has a market cap of 29.7M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while ONMD trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas ONMD's P/E ratio is -31.87. In terms of profitability, SPOK's ROE is +0.13%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, SPOK is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ONMD's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
SPOK vs STRM Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas STRM's P/E ratio is -2.40. In terms of profitability, SPOK's ROE is +0.13%, compared to STRM's ROE of -0.65%. Regarding short-term risk, SPOK is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
SPOK vs RNLX Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SPOK's ROE is +0.13%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, SPOK is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
SPOK vs LIFW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SPOK's ROE is +0.13%, compared to LIFW's ROE of +0.81%. Regarding short-term risk, SPOK is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check LIFW's competition here
SCWorx Corp. (NASDAQ: WORX)
SPOK vs WORX Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, WORX has a market cap of 20.6M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while WORX trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas WORX's P/E ratio is -1.50. In terms of profitability, SPOK's ROE is +0.13%, compared to WORX's ROE of -0.35%. Regarding short-term risk, SPOK is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check WORX's competition here
Babylon Holdings Limited (NYSE: BBLN)
SPOK vs BBLN Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SPOK's ROE is +0.13%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SPOK is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check BBLN's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
SPOK vs ONMDW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, ONMDW has a market cap of 9.9M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while ONMDW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas ONMDW's P/E ratio is -0.07. In terms of profitability, SPOK's ROE is +0.13%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, SPOK is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ONMDW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
SPOK vs ETAO Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SPOK's ROE is +0.13%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SPOK is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
SPOK vs BFRG Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, BFRG has a market cap of 9.6M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while BFRG trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas BFRG's P/E ratio is -1.13. In terms of profitability, SPOK's ROE is +0.13%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, SPOK is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check BFRG's competition here
UpHealth, Inc. (NYSE: UPH-WT)
SPOK vs UPH-WT Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to UPH-WT's ROE of -0.72%. Regarding short-term risk, SPOK is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
SPOK vs UPH Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas UPH's P/E ratio is -0.07. In terms of profitability, SPOK's ROE is +0.13%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SPOK is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check UPH's competition here
Aclarion, Inc. (NASDAQ: ACON)
SPOK vs ACON Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, ACON has a market cap of 4.9M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while ACON trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas ACON's P/E ratio is -0.19. In terms of profitability, SPOK's ROE is +0.13%, compared to ACON's ROE of -0.63%. Regarding short-term risk, SPOK is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ACON's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
SPOK vs MGRX Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, MGRX has a market cap of 4.3M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while MGRX trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas MGRX's P/E ratio is -0.14. In terms of profitability, SPOK's ROE is +0.13%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, SPOK is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
SPOK vs PEARW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SPOK's ROE is +0.13%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SPOK is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
SPOK vs PEAR Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SPOK's ROE is +0.13%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SPOK is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check PEAR's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
SPOK vs HCTI Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, HCTI has a market cap of 2.8M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while HCTI trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas HCTI's P/E ratio is -0.47. In terms of profitability, SPOK's ROE is +0.13%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, SPOK is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HCTI's competition here
Ontrak, Inc. (NASDAQ: OTRK)
SPOK vs OTRK Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas OTRK's P/E ratio is -0.02. In terms of profitability, SPOK's ROE is +0.13%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, SPOK is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
SPOK vs CMAX Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CMAX's P/E ratio is -0.00. In terms of profitability, SPOK's ROE is +0.13%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, SPOK is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
SPOK vs BFRGW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, BFRGW has a market cap of 1.3M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas BFRGW's P/E ratio is -0.22. In terms of profitability, SPOK's ROE is +0.13%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, SPOK is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check BFRGW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
SPOK vs LIFWZ Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to LIFWZ's ROE of +0.81%. Regarding short-term risk, SPOK is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
SPOK vs VSEE Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, VSEE has a market cap of 931.2K. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while VSEE trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas VSEE's P/E ratio is -2.58. In terms of profitability, SPOK's ROE is +0.13%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, SPOK is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
SPOK vs VSEEW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, SPOK's ROE is +0.13%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, SPOK is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
SPOK vs MSPRZ Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to MSPRZ's ROE of +0.81%. Regarding short-term risk, SPOK is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
SPOK vs KERNW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SPOK's ROE is +0.13%, compared to KERNW's ROE of -0.02%. Regarding short-term risk, SPOK is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
SPOK vs KERN Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas KERN's P/E ratio is -0.01. In terms of profitability, SPOK's ROE is +0.13%, compared to KERN's ROE of -0.02%. Regarding short-term risk, SPOK is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
SPOK vs LIFWW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to LIFWW's ROE of +0.81%. Regarding short-term risk, SPOK is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
SPOK vs CMAXW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, SPOK is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
SPOK vs ZCMD Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, ZCMD has a market cap of 16.6K. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while ZCMD trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, SPOK's ROE is +0.13%, compared to ZCMD's ROE of -0.54%. Regarding short-term risk, SPOK is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
SPOK vs ACONW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, ACONW has a market cap of 14.3K. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas ACONW's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to ACONW's ROE of -0.63%. Regarding short-term risk, SPOK is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check ACONW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
SPOK vs MSPRV Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas MSPRV's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to MSPRV's ROE of N/A. Regarding short-term risk, SPOK is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBC)
SPOK vs MTBC Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas MTBC's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to MTBC's ROE of +0.30%. Regarding short-term risk, SPOK is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MTBC's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
SPOK vs MTBCP Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas MTBCP's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to MTBCP's ROE of +0.24%. Regarding short-term risk, SPOK is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check MTBCP's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
SPOK vs NAVA Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas NAVA's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, SPOK is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for SPOK.Check NAVA's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
SPOK vs AFFX Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas AFFX's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, SPOK is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check AFFX's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
SPOK vs CHNG Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CHNG's P/E ratio is -152.72. In terms of profitability, SPOK's ROE is +0.13%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, SPOK is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CHNG's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
SPOK vs KURIU Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas KURIU's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, SPOK is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check KURIU's competition here
Cerner Corporation (NASDAQ: CERN)
SPOK vs CERN Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CERN has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CERN's P/E ratio is 55.84. In terms of profitability, SPOK's ROE is +0.13%, compared to CERN's ROE of +0.14%. Regarding short-term risk, SPOK is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CERN's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
SPOK vs CHNGU Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CHNGU's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, SPOK is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CHNGU's competition here
Castlight Health, Inc. (NYSE: CSLT)
SPOK vs CSLT Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CSLT's P/E ratio is -37.27. In terms of profitability, SPOK's ROE is +0.13%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, SPOK is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CSLT's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
SPOK vs IMS Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, IMS has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas IMS's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to IMS's ROE of +0.27%. Regarding short-term risk, SPOK is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check IMS's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
SPOK vs SMFRW Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas SMFRW's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, SPOK is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SMFRW's competition here
NantHealth, Inc. (NASDAQ: NH)
SPOK vs NH Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, NH has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas NH's P/E ratio is -0.12. In terms of profitability, SPOK's ROE is +0.13%, compared to NH's ROE of +0.35%. Regarding short-term risk, SPOK is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check NH's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
SPOK vs MTBCO Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas MTBCO's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.13%, compared to MTBCO's ROE of +0.24%. Regarding short-term risk, SPOK is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check MTBCO's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
SPOK vs CNVY Comparison November 2026
Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPOK stands at 245.2M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SPOK is priced at $11.76 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPOK currently has a P/E ratio of 13.19, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SPOK's ROE is +0.13%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SPOK is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CNVY's competition here